Enavogliflozin vs. Pioglitazone on Glucose and Atherosclerosis (clinicaltrials.gov) - May 6, 2026 - P4 | N=120 | Recruiting | Sponsor: Seoul National University Bundang Hospital | Trial completion date: Dec 2026 ➔ Dec 2027 | Trial primary completion date: Jun 2026 ➔ Dec 2026
Trial completion date • Trial primary completion date • Atherosclerosis • Cardiovascular • Diabetes • Metabolic Disorders • Type 2 Diabetes Mellitus
|